The Chemours Company (NYSE:CC) Receives Average Recommendation of “Hold” from Analysts

The Chemours Company (NYSE:CC) has been assigned a consensus rating of “Hold” from the eleven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $17.00.

Several analysts have recently weighed in on CC shares. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a research report on Wednesday, October 8th. Truist Financial reduced their price target on shares of Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Monday, November 10th. JPMorgan Chase & Co. decreased their price objective on shares of Chemours from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday, December 3rd. UBS Group cut their target price on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, November 11th. Finally, Royal Bank Of Canada reduced their target price on Chemours from $19.00 to $17.00 and set an “outperform” rating for the company in a report on Monday, November 10th.

Institutional Trading of Chemours

Several institutional investors and hedge funds have recently bought and sold shares of the business. Amalgamated Bank increased its stake in Chemours by 1.7% in the third quarter. Amalgamated Bank now owns 43,528 shares of the specialty chemicals company’s stock valued at $689,000 after purchasing an additional 740 shares during the period. Yousif Capital Management LLC grew its holdings in shares of Chemours by 1.6% during the second quarter. Yousif Capital Management LLC now owns 62,386 shares of the specialty chemicals company’s stock worth $714,000 after buying an additional 968 shares during the last quarter. Man Group plc grew its holdings in shares of Chemours by 0.4% during the second quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock worth $3,104,000 after buying an additional 979 shares during the last quarter. CWM LLC increased its position in Chemours by 34.7% in the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 1,104 shares during the period. Finally, Inspire Investing LLC raised its stake in Chemours by 5.7% during the 1st quarter. Inspire Investing LLC now owns 25,156 shares of the specialty chemicals company’s stock valued at $340,000 after acquiring an additional 1,357 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Chemours Stock Up 1.8%

Shares of NYSE CC opened at $14.96 on Thursday. The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of -6.74 and a beta of 1.61. The company has a debt-to-equity ratio of 13.66, a current ratio of 1.71 and a quick ratio of 0.88. The business has a 50-day moving average of $12.40 and a two-hundred day moving average of $13.63. Chemours has a 1 year low of $9.13 and a 1 year high of $20.12.

Chemours (NYSE:CC) last released its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The company’s revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS. On average, analysts forecast that Chemours will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Friday, November 14th. Chemours’s dividend payout ratio is presently -15.77%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.